Patent · US Active

Method and an apparatus for detecting fracture with significant residual width from previous treatments

US7774140B2 · kind B2 · utility

18Cited by
10References
26Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 30, 2004
Grant dateAug 10, 2010
Priority date
Expiry dateJun 10, 2029

Classification

  • Technology area (CPC E)Fixed Constructions
  • CPC primaryE21B49/008
  • WIPO fieldCivil engineering
  • WIPO sectorOther fields

Abstract

A refracture-candidate diagnostic test is an injection of compressible or slightly compressible fluid at pressures in excess of minimum in-situ stress and formation fracture pressure with pressure decline following injection test recorded to detect a fracture retaining residual width from previous stimulation treatments. The diagnostic consists of small volume injections with injection time being a small fraction of time required for compressible or slightly compressible reservoir fluid to exhibit pseudoradial flow. The fracture-injection portion of a test can be considered as occurring instantaneously. Data measurements are transformed into a constant rate equivalent pressure transformation to obtain adjusted pressures or adjusted pseudovariables which are analyzed to identify dual unit-slope before and after closure periods confirming a residual retaining width.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.